Alice Wolfromm

424 total citations
10 papers, 274 citations indexed

About

Alice Wolfromm is a scholar working on Hematology, Genetics and Infectious Diseases. According to data from OpenAlex, Alice Wolfromm has authored 10 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 2 papers in Infectious Diseases. Recurrent topics in Alice Wolfromm's work include Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (2 papers). Alice Wolfromm is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (2 papers). Alice Wolfromm collaborates with scholars based in France, United States and Belgium. Alice Wolfromm's co-authors include Pierre Fenaux, Éric Rondeau, Laurent Mesnard, Raphaël Itzykson, Lionel Adès, Rami S. Komrokji, F. Dreyfus, Jaroslaw P. Maciejewski, Alan F. List and Ramón V. Tiu and has published in prestigious journals such as Blood, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Alice Wolfromm

9 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alice Wolfromm France	6	92	68	60	56	53	10	274
Nagao Shinagawa Japan	9	84 0.9×	57 0.8×	59 1.0×	18 0.3×	12 0.2×	42	331
Tal Schiller Israel	10	55 0.6×	19 0.3×	95 1.6×	50 0.9×	8 0.2×	28	319
Yuko Kanbayashi Japan	11	58 0.6×	23 0.3×	27 0.5×	34 0.6×	34 0.6×	46	356
Stephan Lorenz Germany	10	40 0.4×	10 0.1×	107 1.8×	78 1.4×	18 0.3×	23	368
Cesarius Singgih Wahono Indonesia	8	33 0.4×	23 0.3×	40 0.7×	27 0.5×	10 0.2×	33	620
Chisato Sato Japan	11	20 0.2×	21 0.3×	82 1.4×	107 1.9×	15 0.3×	30	363
Vittoria Esposito Italy	12	30 0.3×	20 0.3×	79 1.3×	32 0.6×	11 0.2×	27	332
Martina Gaggl Austria	10	33 0.4×	32 0.5×	45 0.8×	33 0.6×	5 0.1×	39	316
Ramón Salinas Spain	9	42 0.5×	40 0.6×	20 0.3×	17 0.3×	10 0.2×	15	257
Randall W. Yatscoff Canada	9	28 0.3×	11 0.2×	113 1.9×	56 1.0×	43 0.8×	15	429

Countries citing papers authored by Alice Wolfromm

Since Specialization

Citations

This map shows the geographic impact of Alice Wolfromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Wolfromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Wolfromm more than expected).

Fields of papers citing papers by Alice Wolfromm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Wolfromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Wolfromm. The network helps show where Alice Wolfromm may publish in the future.

Co-authorship network of co-authors of Alice Wolfromm

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Wolfromm. A scholar is included among the top collaborators of Alice Wolfromm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Wolfromm. Alice Wolfromm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Vandernoot, Isabelle, et al.. (2020). Case Report of an Unusual Tumor in an Adult With a TP53 Germline Mutation. Clinical Lymphoma Myeloma & Leukemia. 21(8). e645–e648.

Wolfromm, Alice, et al.. (2017). Home Administration of Subcutaneous Rituximab Is Safe and Associated with Significant Cost Saving: A Single Center Experience. Blood. 130. 4676–4676. 5 indexed citations

Luque, Yosu, Kévin Louis, Chantal Jouanneau, et al.. (2017). Vancomycin-Associated Cast Nephropathy. Journal of the American Society of Nephrology. 28(6). 1723–1728. 96 indexed citations

Wolfromm, Alice, Christophe Rodriguez, Marc Michel, et al.. (2015). Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice. British Journal of Haematology. 170(2). 192–199. 15 indexed citations

Wolfromm, Alice, Raphaël Porcher, Jérôme LeGoff, et al.. (2014). Viral Respiratory Infections Diagnosed by Multiplex PCR after Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Incidence and Outcome. Biology of Blood and Marrow Transplantation. 20(8). 1238–1241. 24 indexed citations

Adès, Lionel, Mikkael A. Sekeres, Alice Wolfromm, et al.. (2013). Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine. Leukemia Research. 37(6). 609–613. 80 indexed citations

Lainey, Élodie, Alice Wolfromm, Abdul Qader Sukkurwala, et al.. (2013). EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D₃in acute myeloid leukemia cells. Cell Cycle. 12(18). 2978–2991. 37 indexed citations

Baron, Marine, Jean‐Philippe Haymann, Alice Wolfromm, Éric Rondeau, & Laurent Mesnard. (2011). The Case ∣ The smoker and the nephrologist. Kidney International. 79(12). 1385–1386. 14 indexed citations

Adès, Lionel, Mikkael A. Sekeres, Alice Wolfromm, et al.. (2011). Prognostic Factors of Response and Survival in CMML Patients Treated with Azacitidine (AZA). Blood. 118(21). 1726–1726. 2 indexed citations

10.

Wolfromm, Alice, François Dreyfus, Norbert Vey, et al.. (2010). Treatment of Advanced CMML by Azacitidine (AZA) In a Compassionate Program. the GFM Experience In 38 Patients (pts). Blood. 116(21). 4023–4023. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact